Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Lynas Rare Earths stock jumps after CEO retirement plan as rare-earth supply talks heat up

Lynas Rare Earths stock jumps after CEO retirement plan as rare-earth supply talks heat up

Lynas Rare Earths shares rose 3.3% to A$15.56 Wednesday, extending a three-day rally after CEO Amanda Lacaze announced plans to retire after 12 years. Lacaze will remain until the end of the financial year while the board seeks a replacement. The leadership change comes as Australia unveils a A$1.2 billion strategic reserve for critical minerals and G7 finance ministers discuss reducing reliance on Chinese rare earths.
Super Micro Computer stock slides after Goldman Sachs starts SMCI at Sell, flags margin squeeze

Super Micro Computer stock slides after Goldman Sachs starts SMCI at Sell, flags margin squeeze

Shares of Super Micro Computer fell about 5% in after-hours trading Tuesday after Goldman Sachs initiated coverage with a “sell” rating and a $26 price target. The stock hit its lowest level since April, closing at $28.61. Goldman cited margin pressure and limited profitability visibility despite AI-driven growth. The company’s next earnings date is expected in February but remains unconfirmed.
13 January 2026
KNSA stock slides 6% after Kiniksa maps out $900–$920 million ARCALYST outlook — what’s next

KNSA stock slides 6% after Kiniksa maps out $900–$920 million ARCALYST outlook — what’s next

Kiniksa shares fell 6.1% to $38.61 Tuesday after the company projected 2026 ARCALYST revenue of $900–$920 million, below the prior year’s growth rate. The drop followed an intraday low of $38.27. Wedbush raised its price target to $50, citing increased prescriber numbers and longer therapy use. Kiniksa reported $677.5 million in 2025 ARCALYST revenue and ended the year with $414.1 million in cash.
Harmony Biosciences stock drops after ZYN002 exit as 2026 Wakix sales outlook tops $1 billion

Harmony Biosciences stock drops after ZYN002 exit as 2026 Wakix sales outlook tops $1 billion

Harmony Biosciences shares fell 6.4% to $35.82 Tuesday after the company cut its Fragile X program and issued 2026 sales guidance. Harmony forecast Wakix net revenue of $1.0–$1.04 billion for 2026 and confirmed it will phase out ZYN002. Preliminary Wakix revenue for 2025 was about $868 million. CEO Jeffrey Dayno is set to present at the J.P. Morgan Healthcare Conference later Tuesday.
13 January 2026
Asana stock drops 7% today as software names slide after CPI — what to watch next

Asana stock drops 7% today as software names slide after CPI — what to watch next

Asana shares fell 7.1% to $12.04 Tuesday afternoon, underperforming major indexes after U.S. inflation data showed a 2.7% annual rise in December. The drop mirrored declines in other cloud software stocks. Company news was limited, though Asana launched a new automation feature late Monday. Investors are watching the Fed’s Jan. 27-28 meeting and Asana’s fiscal year-end on Jan. 31.
Navitas Semiconductor (NVTS) stock slides 11% in choppy trade — what investors are watching next

Navitas Semiconductor (NVTS) stock slides 11% in choppy trade — what investors are watching next

Navitas Semiconductor shares fell about 11% Tuesday, closing at $9.33 after volatile trading. The drop came ahead of CEO Chris Allexandre’s scheduled appearance at the Needham Growth Conference on Wednesday. Investors are watching for updates on the company’s shift to higher-power GaN and SiC chips for AI data centers. The broader chip sector rose, with the iShares Semiconductor ETF up 1%.
13 January 2026
iRhythm (IRTC) stock slides as 2026 outlook and holding-company switch land

iRhythm (IRTC) stock slides as 2026 outlook and holding-company switch land

iRhythm Technologies shares dropped 7.5% to $156.24 Tuesday after the company announced 2026 sales targets and a restructuring plan during the J.P. Morgan Healthcare Conference. The company raised its 2025 revenue forecast above $740 million and projected 2026 revenue of $870–$880 million. iRhythm also created a new holding-company structure, effective Jan. 12, with no change to its ticker symbol.
13 January 2026
Why Super Micro Computer stock is sliding: Goldman starts SMCI at Sell with $26 target

Why Super Micro Computer stock is sliding: Goldman starts SMCI at Sell with $26 target

Super Micro Computer shares fell 6.3% to $28.22 after Goldman Sachs initiated coverage with a Sell rating and a $26 price target, citing limited profit visibility. The stock has dropped nearly 45% in three months. Goldman expects profit margins to fall to 7.5% by 2026, down from over 15% in 2022. Increased competition and higher component costs are pressuring margins.
13 January 2026
Wall Street slips on JPMorgan warning as December inflation holds at 2.7% — Visa, Mastercard tumble

Wall Street slips on JPMorgan warning as December inflation holds at 2.7% — Visa, Mastercard tumble

U.S. stocks fell Tuesday, with the Dow down 338 points, as financials slumped after JPMorgan warned a proposed credit-card rate cap could hurt consumers. Visa dropped 4.7% and Mastercard lost 5.3%. December CPI rose 0.3%, annual inflation held at 2.7%, and core inflation ran at 2.6%. Traders still expect at least two Fed rate cuts later this year.
1 187 188 189 190 191 535

Stock Market Today

TSMC stock price jumps as chip rally returns — what to watch before Feb. 10 sales update

7 February 2026
TAIPEI, Feb 7, 2026, 23:19 (GMT+8) — Market closed. Taiwan Semiconductor Manufacturing Co’s U.S.-listed American depositary receipts (TSM) jumped 5.5% on Friday to $348.85, after trading between $330.15 and $350.81. In Taipei, the stock (2330.TW) closed up 0.85% at NT$1,780, its high for the day, with about 35 million shares changing hands. (Investing.com) The bounce matters because the AI trade has been wobbling, and money has started to move away from software and back into the hardware that runs large models. Semiconductor stocks are up about 65% since early 2025, while software and services shares are down 8%, a Reuters
Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Go toTop